Journals / Fiziksel Tıp ve Rehabilitasyon Bilimleri Dergisi / 2010 / Cilt: 13 - Sayı: 3

Retinoid induced hyperostosis in a patient with darier's disease

Darier hastalığı olan bir olguda retinoide bağlı hiperostozis

Pages
104–107
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Dermatologists should closely follow up their patients using retinoids for possible musculoskeletal side effects and consult to physical medicine and rehabilitation physicians when required.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Darier's disease is a rare autosomal dominantly inherited genodermatosis.
📊
Key Findings & Data:In this case report, a 53-year-old man who was taking acitretin, a second generation retinoid, for 3.5 years due to Darier's disease complaining of pain, weakness and severe stiffness secondary to acitretin induced hyperostosis leading to myelomalacia is presented.
💡
Conclusion & Impact:Dermatologists should closely follow up their patients using retinoids for possible musculoskeletal side effects and consult to physical medicine and rehabilitation physicians when required.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Darier's disease is a rare autosomal dominantly inherited genodermatosis. Retinoids are commonly used in its treatment and the most common side effect of retinoids on bone is hyperostosis. In this case report, a 53-year-old man who was taking acitretin, a second generation retinoid, for 3.5 years due to Darier's disease complaining of pain, weakness and severe stiffness secondary to acitretin induced hyperostosis leading to myelomalacia is presented. If musculoskeletal follow up is neglected in long term retinoid use, neurological complications may develop leading to severe functional limitations. Dermatologists should closely follow up their patients using retinoids for possible musculoskeletal side effects and consult to physical medicine and rehabilitation physicians when required.

Özet

Darier hastalığı, nadir görülen otozomal dominant geçişli bir genodermatozdur. Tedavisinde kullanılan retinoidlerin kemikte en sık görülen yan etkisi hiperostozistir. Bu olgu sunumunda, Darier hastalığı nedeniyle 3.5 yıldır ikinci nesil bir retinoid olan asitretin kullanan 53 yaşındaki erkek hastada ilaca bağlı gelişen ağrı, güçsüzlük ve ileri derecede kısıtlılığa ve servikal myelomalaziye yol açan hiperostozisten bahsedilmektedir. Uzun süre retinoid kullanımında kas-iskelet sistemi takibinin ihmal edilmesi durumunda işlevleri ileri derecede kısıtlayan nörolojik komplikasyonlar gelişebilmektedir. Dermatologlar tarafından izlenen ve retinoid kullanan hastalar, kas-iskelet sistemine ait olası yan etkiler açısından yakın takip edilmeli ve gerektiğinde fiziksel tıp ve rehabilitasyon hekimine yönlendirilmelidir.

🔖

Cite This Article

BARUTÇU, F. G., TAŞKIRAN, Ö. Ö., DEMİRSOY, N. (2010). Retinoid induced hyperostosis in a patient with darier's disease. Fiziksel Tıp ve Rehabilitasyon Bilimleri Dergisi, Cilt: 13 - Sayı: 3, 104–107. https://ajindex.com/articles/190569

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Sterry W, Paus R, Burgdorf W. Genodermatoses. In: Sterry W, Paus R, Burgdorf W (eds). Thieme Clinical Companions: Dermatology (6th ed). Thieme, Germany, 2006. pp. 332-71
  2. Milstone L, Rizzo W, Richard G. Disorders of Cornification. In: Spitz JL (ed). Genodermatoses ( A Clinical Guide to Genetic Skin Disorders) (2nd ed). Lippincott Williams & Wilkins, USA, 2005. pp. 2-48
  3. Geilen CC, Almond-Roesler B, Orfanos CE. Therapeutic uses of retinoids in skin diseases. In: Livrea MA (ed). Vitamin A and Retinoids: An update of Biological Aspects and Clinical Applications. Birkhauser Verlag, Basel, Switzerland, 2000. pp. 251-9
  4. Ebadi M. Desk reference of Clinical Pharmacology (2nd Edition). Taylor & Francis Group, USA, 2008. pp. 365
  5. Richard A, Barbara L. Introduction to dermatological treatment. In: Ashton R, Leppard B (eds). Differential diagnosis in Dermatology ( 3rd edition). Radceliffe Publishing Ltd. Oxon, United Kingdom, 2005. pp. 21-54
  6. Gollnick HP. Oral Retinoids.efficacy and toxicity in psoriasis. Br J Dermatol 1996:135:6-17
  7. Johansson S, Lind PM, Hakansson H, Oxlund H, Orberg J, Melhus H. Subclinical hypervitaminosis A causes fragile bones in rats. Bone 2002:31;287-94
  8. Silverman AK, Ellis CN, Voorhees JJ. Hypervitaminosis A syndrome: a paradigm of retinoid side effects. J Am Acad Dermatol 1987;16:1027-39
  9. Melhus H, Michaelsson K, Kindmark A, et. al. Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Intern Med 1998;129:770-8
  10. White SI, MacKie RM. Bone with changes associated with oral retinoid therapy. Pharmacol Ther 1989;40:137-44
  11. Brecher AR, Orlow SJ. Oral retinoid therapy for dermatologic conditions in children and adolescents. J Am Acad Derrmatol 2003;49:171-82
  12. DiGiovanna JJ. Isotretinoin effects on bone. J Am Acad Dermatol 2001;45:176-82
  13. Gollnick HP. Oral Retinoids--efficacy and toxicity in psoriasis. Br J Dermatol 1996:135:6-17
  14. Katz HI, Waalen J, Leach EE. Acitretin in psoriasis: An overview of adverse effects. J Am Acad Dermatol September 1999:41:7-12
  15. Warren RB, Griffiths CE. Systemic therapies for psoriasis: Methotrexate, retinoids, and cyclosporine. Clin Dermatol. 2008;26:438-47
  16. Mork NJ, Austad J, Kolbenstvedt. Bamboo Spine Mimicking Bekhterev’s Disease Caused by Long-term Acitretin Treatment. Acta Derm Venereol 2006:86:452-3
  17. Atalay A, Altaykan A, Ergin G, Gökçe-Kutsal Y. Reversible sclerotic changes of lumba